secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABVC BIOPHARMA, INC. (ABVC)
CIK:        0001173313
Form:       8-K
Filed at:   2024-04-19T23:59:59+00:00
Accession:  0001213900-24-034583
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ABVC BioPharma shareholders re-elect 11 directors, ratify auditor, approve equity plan increase at 2024 annual meeting
--------------------------------------------------------------------------------

- All 11 director nominees were re-elected; quorum of 5,736,015 shares (54.31%) represented.
- Ratified WWC P.C. CPA as independent auditor for FY2024 with 5,449,292 votes for.
- Approved issuance of shares exceeding 20% of outstanding stock to Lind Global Fund II under convertible notes/warrants.
- Increased Amended 2016 Equity Incentive Plan to 1,283,002 shares (12.15% of outstanding).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1173313/000121390024034583/0001213900-24-034583-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1173313/000121390024034583/ea020408501-8k_abvcbio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-034583

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer